Please login to the form below

The other side of … rheumatoid arthritis

For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed...

The other side of … rheumatoid arthritis

“I harassed my GP enough to get it caught early”

Meet Georgie.

At age 26, Georgie was diagnosed with rheumatoid arthritis, an autoimmune inflammatory condition that affects up to 1% of the population worldwide.

Suffering from such incredible pain every morning that stopped her from doing simple things like getting dressed or brushing her teeth, Georgie sought help. And refused to stop until she got answers.

What we can learn from Georgie’s story

Georgie’s story is a positive one, one where the short time to diagnosis (2–3 months) meant that the disease was caught and treated early, causing minimal damage to her joints. So what contributed to this?

On the one hand, time-lags between initial symptoms and diagnosis for rheumatoid arthritis have universally decreased in recent years (eg from 24 months in 2000–2002 to 6 months in 2009–2011). Key to this has probably been a shift in clinicians’ knowledge of the disease and the motivation to treat – likely tied to their beliefs about the consequences of the disease and the impact of early diagnosis.

At the same time, patient empowerment remains an integral driver to accelerating diagnosis and treatment.

And Georgie is a great example of a patient who empowered herself by asserting her interests.

She had an awareness of her own body and what is ‘normal’. So when her doctors initially sent her home, she didn’t give up – within 2 weeks, she was back, asking for answers. When the blood tests came back normal, she wasn’t demoralised. Her awareness, together with the desire to live pain-free, gave her the motivation and confidence to assert her interests in her interactions with healthcare professionals and persist until a referral and diagnosis were reached.

But she shouldn’t have to empower herself

Georgie’s success comes from being assertive – and not all patients will be. So what about them? Will they end up with a delayed diagnosis and the consequent joint damage that goes with it?

Communication is key here; and both parties need to be involved. The environment has to engage patients and give them the knowledge, confidence and skills they need to be active players in their care. Which will be necessary to bridge the gap between patients and doctors and enable them to share the knowledge they each have and help them make informed mutual decisions.

Clearly great strides have been made in rheumatoid arthritis. But we can’t pause now; by looking at stories like Georgie’s, we have to keep assessing the gaps and continuously evolve the environment.

28th October 2020

Share

Tags

Company Details

Frontera Group

+44 (0) 7817 410079

Contact Website

Address:
St. John’s House
54 St. John’s Square
London
EC1V 4JL

Latest content on this profile

Frontera Group continues growth
Frontera London, part of the Frontera Group, is delighted to announce the additions of Emma Langley and Mark Frost to the senior leadership team.
Frontera Group
>> FAST FORWARD How pandemics accelerate new thinking and early adoption in healthcare.
Spanish Flu killed > 2% of the world, but accelerated healthcare for all. HOW is COVID-19 accelerating healthcare again and WHY does evidence say being an innovator matters?
Frontera Group
The other side of ... gout

Frontera Group
Frontera wins at IPA Best of Health 2016

Frontera Group
Why Don't More People Want to Change the World?
Healthcare is critical. But healthcare will never be fixed to a point where we can say that it's done. Instead, it's about looking at things in new ways, exploring new ideas for changing behaviour to improve outcomes. For everyone. So, why don't more people try to do different?
Frontera Group
Patient Truth is Out There
Patient centricity, patient focus, patients first – words that are on everyone’s lips these days. But what do they really mean? Where does the patient voice fit in? And what do we stand to gain by really listening to patients?  We spoke to patients, academics, Pharma, not-for-profit and industry professionals to find out the value of the patient voice. The power it holds to transform health outcomes, which benefits not only the healthcare system but also the pharmaceutical industry.  Download our white paper and explore:  What people mean when they talk about patient centricity The benefits of listening to patients – for patients, Pharma and the healthcare system as a whole The challenges to capturing the patient voice and how technology can help deliver it How Pharma should evolve its practices to drive patient activation
Frontera Group